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Purpose. Transversus abdominis plane (TAP) blocks have been shown to reduce pain and opioid requirements after abdominal
surgery. The aim of the present case series was to demonstrate the use of TAP catheter injections of bupivacaine after major
abdominal surgery. Methods. Fifteen patients scheduled for open colonic resection surgery were included. After induction of
anesthesia, bilateral TAP catheters were placed, and all patients received a bolus dose of 20mL bupivacaine 2.5mg/mL with
epinephrine 5µg/mL through each catheter. Additional bolus doses were injected bilaterally 12, 24, and 36hrs after the ﬁrst
injections. Supplemental pain treatment consisted of paracetamol, ibuprofen, and gabapentin. Intravenous morphine was used as
rescue analgesic. Postoperative pain was rated on a numeric rating scale (NRS, 0–10) at regular predeﬁned intervals after surgery,
andconsumptionofintravenousmorphinewasrecorded. Results.TheTAPcatheterswereplacedwithoutanytechnicaldiﬃculties.
NRSscoreswere≤3atrestand≤5duringcoughat4,8,12,18,24,and36hrsaftersurgery.Cumulativeconsumptionofintravenous
morphine was 28 (23–48)mg (median, IQR) within the ﬁrst 48postoperative hours. Conclusion. TAP catheter bolus injections can
be used to prolong analgesia after major abdominal surgery.
1.Introduction
Epidural analgesia is commonly used for the treatment of
postoperativepainaftermajorabdominalsurgerydespitethe
well-knownrisksandthelonglistofcontraindications[1,2].
During the last few years, interest has grown concerning
the use of transversus abdominis plane (TAP) block as an
alternative to epidural analgesia. A TAP block provides anal-
gesia of the anterolateral abdominal wall through blockade
of the lateral and anterior cutaneous branches of Th7 to
L1 as shown in volunteers by McDonnell et al. [3]. Clinical
trials have shown that a bilateral single-shot TAP block
reduces pain after large bowel resection and total abdominal
hysterectomy [4, 5].
The duration of a single-shot TAP block is limited by the
pharmacokinetics of the local anesthetic used, and therefore,
the use of TAP catheters has been described in order to
prolong the eﬀect of the TAP block through infusion or
injection of local anesthetic [6–10]. Only two prospective,
randomized studies have been carried out [11, 12]. Kadam
and Field [11] randomized 40 patients undergoing non-
speciﬁed major abdominal surgery to receive either a single-
shot TAP block at the end of surgery followed by a 72hr
infusion at 8–10mL/hr of 0.2% ropivacaine 2mg/mL and
fentanyl patient-controlled analgesia (PCA) (TAP group,
n = 20) or fentanyl PCA only (control group, n = 20). Pain
scores and consumption of fentanyl were signiﬁcantly lower
in the TAP group on the ﬁrst and second days after surgery.
Niraj et al. [12] randomized 62 patients undergoing major
hepatobiliary or renal surgery to receive either intermittent
bolus injections of 1mg/kg bupivacaine 3.75mg/mL every
8hr via subcostal TAP catheters placed at the end of surgery
(TAP group, n = 29) or an epidural infusion of bupivacaine
1.25mg/mL and fentanyl 2µg/mL (epidural group, n = 33).2 Anesthesiology Research and Practice
There were no signiﬁcant diﬀerences in visual analog pain
scores (VAS, 0–10) between the epidural group and the TAP
group during coughing at 8hr (VAS = 4.0 (2.5, 5.3 [0–8.5])
and 4.0 (2.3, 6.0 [0–7.5]), resp.) and at 72hr (VAS = 2.5
(1.0, 5.0 [0–6.0]) and 2.0 (0.8, 4.0 [0–5.0]), resp.). Values are
median (IQR (range)).
So far, no trials have examined the analgesic eﬀect of
intermittent bolus injections via TAP catheters placed preop-
eratively using the posterior approach for major abdominal
surgery. The purpose of the present case series was to
demonstrate the use of intermittent bolus injections of
bupivacaine through bilateral TAP catheters as part of a
multimodalanalgesicregimenintheﬁrst48hoursafteropen
colonic resection surgery.
2.MaterialsandMethods
The case series was registered at http://www.clinicaltrials
.gov/, ID: NCT01395043, and approved by the regional
ethical committee. Fifteen patients undergoing elective
lower major abdominal surgery with laparotomy and colon
resection were prospectively included. As this was a case
series, only registration of the patients accepting to par-
ticipate was done. Enrolment started in September 2010
and ﬁnished in June 2011. Written informed consent was
obtained before enrollment. Primary exclusion criteria were
allergies to morphine or bupivacaine or inability to provide
informed consent. Secondary exclusion criteria were reoper-
ation within the ﬁrst 48 hours or postoperative mechanical
ventilation.
General anesthesia was induced with propofol 1-2mg/kg
or thiopenthal 3–5mg/kg, remifentanil 1µg/kg and sux-
amethonium 1mg/kg or cisatracurium 0.15mg/kg at the
discretion of the attending anesthesiologist. Following endo-
tracheal intubation, anesthesia was maintained with sevoﬂu-
rane at MAC 1 and remifentanil 0.3–1.0µg/kg/min. An
intravenous dose of fentanyl 1-2µg/kg was given at the end
of surgery. After induction of anesthesia, TAP catheters were
placed bilaterally as described below. Surgery was performed
by trained surgeons with all incisions performed in the lower
abdominal wall below the umbilicus.
The TAP catheters were placed by the same experienced
anesthetist under sterile conditions. A linear high-frequency
ultrasound probe (HFL38, 13–6MHz) covered with a sterile
sheath (SITE-RITE∗ Probe Cover kit, Bard Access Systems
Inc, Salt Lake City, USA) was used. An 18-gauge Touhy
needle (Perican, B. Braun, Melsungen AG, Melsungen,
Germany) was advanced in plane in a medial to lateral
direction with ultrasound guidance using a SonoSite S-
Nerve (SonoSite, Bothell, WA, USA) apparatus. The point
of insertion was between the anterior and the mid-axillary
line and between the lower costal margin and the iliac
crest, based on the best visualization of TAP, expected
surgical incision and preoperative stoma site marking. After
reaching the TAP with the Touhy needle, hydrodissection
was done with 10mL of isotonic saline. An epidural
catheter (Braun Periﬁx catheter, B. Braun, Melsungen AG,
Melsungen, Germany) was introduced through the Touhy
needle. With the Touhy needle bevel facing posteriorly,
the catheter was advanced 15–20cm inside the TAP in
order to avoid displacement during patient movement and
ambulation. After hydrodissection the advancement of the
TAP catheter was unproblematic, although advancing the
catheter less than 15cm would probably have been suﬃcient
to avoid displacement. The Touhy needle was removed and
a ﬁlter (Periﬁx Filter 0.2µm, B. Braun, Melsungen AG,
Melsungen, Germany) was connected to the catheter. Twenty
mL of bupivacaine 2.5mg/mL with epinephrine 5µg/mL was
injected via each catheter with direct real-time ultrasound
visualizationtoensurecorrectplacementoftheTAPcatheter.
The TAP catheters were ﬁxed using an epidural plaster
(EPI-FIX, Unomedical Ltd, Stonehouse, Great Britain) and
Meﬁx self-adhesive ﬁxation (M¨ olnlycke, Health Care AB,
Gothenburg, Sweden).
Three additional bolus doses of 20mL bupivacaine
2.5mg/mL were injected bilaterally via the TAP catheters 12,
24, and 36hr after the ﬁrst bolus dose (i.e., if duration of
surgery was 2hr, the second, third, and fourth bolus doses
were given 10, 22, and 34hr after end of surgery, resp.). In
addition, all patients received a postoperative multimodal
analgesic regimen consisting of paracetamol 1000mg every
6hr, ibuprofen 400mg every 8hr, and gabapentin 400mg
every 8hr daily. Intravenous (IV) morphine 5–10mg was
used as rescue medication with the aim of ensuring a
pain intensity of ≤3a tr e s ta n d≤5 during coughing on
a NRS, 0–10. Postoperative pain is generally considered to
be acceptable if pain intensity is kept below these NRS
levels.
Intensity of pain was assessed 0, 1, 2, 4, 8, 12, 18, 24, and
36hr after surgery. Cumulative consumption of morphine
within the ﬁrst 48 postoperative hours was also recorded.
3. Results
Fifteen patients, 7 males and 8 females, aged 54 to 80 years,
were included in the study (see Table 1 for baseline charac-
teristics). All patients received bilateral TAP catheters after
induction of anesthesia. Six patients underwent extensive
surgery due to inﬁltration of the primary cancer leading to
furtherresectionofnearbytissuesuchaspelvicﬂoor,urinary
bladder, gastric ventricle, and liver. None of the patients
underwent reoperation or mechanical ventilation within the
ﬁrst 48hr.
A sc a nb es e e nf r o mF i g u r e s1 and 2, the median
NRS scores at rest and during coughing were ≤3a n d≤5,
respectively, except for the ﬁrst 2 postoperative hours. The
h i g hN R Ss c o r e sa t0 ,1 ,a n d2h rw e r ep r i m a r i l yd u et oh i g h
scores among the patients who underwent extensive surgery.
The cumulative consumption of IV morphine was
28 (23–48)mg (median, IQR) within the ﬁrst 48 post-
o p e r a t i v eh o u r s .P a t i e n t sw h ou n d e r w e n tl e s se x t e n s i v e
surgery (n = 9) consumed 23 (21–28)mg (median, IQR)
IV morphine, whereas patients who underwent extensive
surgery (n = 6) consumed 50 (34–60)mg (median, IQR)
IV morphine. Morphine was administrated intravenously,
except for two patients who received a total of 6 doses of oral
morphine. In those cases a 1:3 ratio was used for conversion
from oral to IV morphine.Anesthesiology Research and Practice 3
Table 1: Baseline characteristics (n = 15).
Gender (M/F) 7/8
Age (yr) 66 (54–81)
ASA
I3
II 6
III 6
Body mass index 27.0 (21.1–36.4)
Duration of surgery (min) 130 (65–240)
Blood loss during surgery (mL) 200 (25–2200)
Comorbidity∗ (n)1 3
Arterial hypertension 6
Other cardiac disease 2
Chronic obstructive pulmonary disease 2
Previous stroke 3
Diabetes 1
Other comorbidity† 9
Preoperative consumption of opioids (n)3
∗5 patients had one comorbidity and 8 patients had two or more
comorbidities.
†Other co-morbidity included myxoedema, arthritis, benign prostatic
hyperplasia, former deep venous thrombosis, dyspepsia, and previous
pulmonary tuberculosis.
Values are median (range), otherwise absolute number of cases recorded.
ASA = American Society of Anesthesiologists.
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Figure 1: Intensity of pain at rest. Intensity of pain was assessed on
a numerical rating scale (0–10) 0, 1, 2, 4, 8, 12, 18, 24, 36hr after
end of surgery. Data are expressed as median (interquartile range).
n = 15 (n = 11 and n = 14 after 12 and 18hr, resp.).
All patients, except one who was severely walking-
impaired before surgery, were mobilized and walked on the
day of surgery. No complications, infections, or systemic
side eﬀects to bupivacaine were observed during the 48hr
study period. In two patients, one of the TAP catheters was
accidentally pulled out during mobilization on the second
postoperative day and hence the fourth dose of bupivacaine
was only given in the remaining catheter. In another patient,
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Figure 2: Intensity of pain during coughing. Intensity of pain
was assessed on a numerical rating scale (0–10) 0, 1, 2, 4, 8, 12,
18, 24, 36hr after end of surgery. Data are expressed as median
(interquartile range). n = 15 (n = 11 and n = 14 after 12 and
18hr, resp.).
one of the TAP catheters was removed before surgery on
request of the surgeon due to close proximity to the surgical
ﬁeld. The catheter was replaced immediately after surgery.
4. Discussion
Ultrasound guided TAP block is a relatively new technique
and data on the eﬃcacy of TAP block for abdominal
analgesia are sparse and conﬂicting [13–17]. Very limited
data describe the use and eﬀect of TAP catheters in order
to prolong the analgesic eﬀect of TAP block by continuous
infusion or repeated bolus injections of local analgesics.
In the present case series, bolus injections were used in
order to achieve repeated hydrodissection of the TAP and
a signiﬁcant spread of local anesthetic in the entire TAP.
We showed that administration of repeated bolus doses
of bupivacaine as part of a multimodal analgesic regimen
resulted in acceptable pain-scores and relatively low opioid
requirements, comparable to what has been found in other
studies [11, 12].
The present case series also demonstrates the impor-
tance of a careful selection of patients when choosing this
technique for postoperative analgesia. The patients with
extensive surgery required more morphine and had high
levels of pain during the ﬁrst 2 postoperative hours. The TAP
block only generates analgesia of the anterolateral abdominal
wall extending to the anterior axillary line; hence, there is
no analgesic eﬀect to cover the pelvic ﬂoor, visceral pain,
retroperitoneum, or the abdominal wall posterior to the
anterior axillary line. The moderate or even poor pain
control during the ﬁrst two hours postoperatively was largely
caused by poor analgesic eﬀect in the subgroup of patient
who underwent extensive surgery. As the TAP catheter has
no eﬀect on visceral pain or pain deriving from the pelvis
ﬂoor, we would expect the TAP catheters to be insuﬃcient to
that type of surgery.4 Anesthesiology Research and Practice
The systemic eﬀect of local analgesics is known to reduce
postoperative pain, [18–20] and the plasma concentration of
local analgesics used for TAP block has been shown to reach
considerable levels with the commonly used catheter dosages
[21, 22]. Plasma levels of bupivacaine were not measured in
the present study. With a total dose of 100mg bupivacaine
every 12hr, a robust safety margin concerning toxic eﬀect
was secured. However, it is unknown whether the systemic
eﬀect of the bupivacaine administered had any eﬀect on pain
levels or opioid requirements.
S o m ep r a c t i c a li s s u e sm u s tb ec o n s i d e r e d .P l a c i n gaT A P
catheter can be done with the patient in the supine position
and with less concern for coagulopathy and hemodynamics
compared to the placement of an epidural catheter. The
posterior insertion permits preoperative placement, as the
catheter is kept away from the surgical ﬁeld. Preoper-
ative placement is preferable as drapes, tissue oedema,
intraabdominal air, and surgical drains may hamper the
ultrasonographic visualization of the TAP. Also, a joint eﬀort
must be made with the surgeons and nurses to reduce
the risk of soiling the TAP-dressing, accidental pulling or
dislodgement of the catheter during placement, or removal
of the surgical dressing. Visualization of the Touhy needle
and the epidural-type catheter with ultrasound can be
diﬃcult with the equipment used in the present study.
However, more echogenic needles and catheters are already
on the market and they may facilitate both visualization and
placement of a TAP catheter.
We acknowledge several limitations of the present case
series. First, it is not randomized or blinded. Second, only
a limited number of patients was included. Third, the
dermatome level of the block was not registered. Even when
these limitations are taken into consideration, intermittent
bolus injections of bupivacaine via TAP catheters seem to
be a promising alternative to epidural analgesia. However,
randomized, double-blind trials are necessary in order to
evaluate the eﬃcacy of TAP catheter analgesia.
5. Conclusion
TAP catheter bolus injections can be used after major
abdominal surgery as part of a multimodal analgesic
regimen. The technique is probably best suited for non-
extensive surgery where the pain is derived primarily from
the abdominal wall incision. This case series presents the
use of ultrasound-guided bilateral transversus abdominis
plane catheters, placed using the posterior approach, with
intermittent bolus injections of bupivacaine, as part of
a multimodal analgesic regimen after major abdominal
surgery.
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